Australia markets close in 5 hours 3 minutes

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.73-0.16 (-1.47%)
At close: 04:00PM EDT
10.73 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 637.45M
Enterprise value 465.26M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)232.13
Price/book (mrq)N/A
Enterprise value/revenue 179.36
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3-16.68%
S&P500 52-week change 328.04%
52-week high 317.02
52-week low 36.07
50-day moving average 39.84
200-day moving average 39.80

Share statistics

Avg vol (3-month) 3772.6k
Avg vol (10-day) 3586.61k
Shares outstanding 558.54M
Implied shares outstanding 658.54M
Float 843.28M
% held by insiders 18.91%
% held by institutions 190.31%
Shares short (30 Apr 2024) 411.8M
Short ratio (30 Apr 2024) 416.5
Short % of float (30 Apr 2024) 441.40%
Short % of shares outstanding (30 Apr 2024) 420.15%
Shares short (prior month 28 Mar 2024) 410.65M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,658.68%

Management effectiveness

Return on assets (ttm)-51.74%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.59M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -206.55M
Net income avi to common (ttm)-246.63M
Diluted EPS (ttm)-4.46
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)322.23M
Total cash per share (mrq)5.51
Total debt (mrq)478.75M
Total debt/equity (mrq)N/A
Current ratio (mrq)7.83
Book value per share (mrq)-2.54

Cash flow statement

Operating cash flow (ttm)-166.93M
Levered free cash flow (ttm)-111.35M